Skip to main content

Advertisement

SpringerLink
Log in

Poly (lactic-co-glycolic acid) as a controlled release delivery device

  • Published:
Journal of Materials Science: Materials in Medicine Aims and scope Submit manuscript

Abstract

Poly (lactic-co-glycolic acid) (PLGA) is a biodegradable polymer used to make resorbable sutures, and is also used in other applications in tissue engineering. Being an artificial polymer, its degradation rate can be tailored to suit its application. It can be easily moulded into structures with suitable mechanical strength and degrades into relatively harmless products in the body. Its adjustable degradation rate also makes it a potentially excellent controlled release delivery device. However, the functionalization of PLGA with bioactive molecules usually requires extensive chemical modification. Chemical modification may compromise the mechanical strength of PLGA and inactivate the bioactive molecules. In this paper, a study is done to investigate the coating of an angiogenic factor on unmodified PLGA suture substrates for the differentiation of human mesenchymal stem cells (hMSC) into endothelial cells (EC). The results show that the method used to anchor vascular endothelial growth factor (VEGF) onto the PLGA surface can enable the gradual release of VEGF from the substrate into solution to induce the differentiation of hMSCs into ECs. Thus, this method can potentially be used to coat PLGA materials like sutures, meshes and scaffolds, rendering them functional as effective controlled release delivery devices for a wide range of bioactive molecules.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Wen F, Chang S, Toh YC, Teoh SH, Yu H. Development of poly (lactic-co-glycolic acid)-collagen scaffolds for tissue engineering. Mater Sci Eng C. 2006;27:285–92. doi:10.1016/j.msec.2006.05.007.

    Article  Google Scholar 

  2. Nakamura M, Abe Y, Tokunaga T. Pathological significance of vascular endothelial growth factor A isoform expression in human cancer. Pathol Int. 2002;52:331–9. doi:10.1046/j.1440-1827.2002.01367.x.

    Article  PubMed  CAS  Google Scholar 

  3. Sharon JL, Puleo DA. Immobilization of glycoproteins, such as VEGF, on biodegradable substrates. Acta Biomater. 2008;4:1016–23. doi:10.1016/j.actbio.2008.02.017.

    Article  PubMed  CAS  Google Scholar 

  4. Chu CC. Hydrolytic degradation of polyglycolic acid: tensile strength and crystallinity study. J Appl Polym Sci. 1980;26:1727–34. doi:10.1002/app.1981.070260527.

    Article  Google Scholar 

  5. Lee ES, Na K, Bae YH. Polymeric micelle for tumor pH and folate-mediated targeting. J Control Release. 2003;91:103–13. doi:10.1016/S0168-3659(03)00239-6.

    Article  PubMed  CAS  Google Scholar 

  6. Stella B, Arpicco S, Peracchia MT, Desmaele D, Hoebeke J, Renoir M, et al. Design of folic acid-conjugated nanoparticles for drug targeting. J Pharm Sci. 2000;89:1452–64. doi:10.1002/1520-6017(200011)89:11<1452::AID-JPS8>3.0.CO;2-P.

    Article  PubMed  CAS  Google Scholar 

  7. Catiker E, Guner A, Gumusderelioglu M. Degradation of PLA, PLGA homo- and copolymers in the presence of serum albumin: a spectroscopic investigation. Polym Int. 2000;49:728–34. doi:10.1002/1097-0126(200007)49:7<728::AID-PI443>3.0.CO;2-3.

    Article  CAS  Google Scholar 

  8. Gehling UM, Ergun S, Schumacher U, Wagener C, Pantel K, Otte M, et al. In vitro differentiation of endothelial cells from AC133-positive progenitor cells. Blood. 2000;95:3106–12.

    PubMed  CAS  Google Scholar 

  9. Quirici N, Soligo D, Caneva L, Servida F, Bossolasco P, Deliliers GL. Differentiation and expansion of endothelial cells from human bone marrow CD133(+) cells. Br J Haematol. 2001;115:186–94. doi:10.1046/j.1365-2141.2001.03077.x.

    Article  PubMed  CAS  Google Scholar 

  10. Reyes M, Lund T, Lenvik T, Aguiar D, Koodie L, Verfaillie CM. Purification and ex vivo expansion of postnatal human marrow mesodermal progenitor cells. Blood. 2001;98:2615–25. doi:10.1182/blood.V98.9.2615.

    Article  PubMed  CAS  Google Scholar 

  11. Ennett AB, Kaigler D, Mooney DJ. Temporally regulated delivery of VEGF in vitro and in vivo. J Biomed Mater Res. 2006;79:176–84. doi:10.1002/jbm.a.30771.

    Article  Google Scholar 

  12. Jackson DE. The unfolding tale of PECAM-1. FEBS Lett. 2003;540:7–14. doi:10.1016/S0014-5793(03)00224-2.

    Article  PubMed  CAS  Google Scholar 

  13. Oswald J, Boxberger S, Jorgensen B, Feldmann S, Ehninger G, Bornhauser M, et al. Mesenchymal stem cells can be differentiated into endothelial cells in vitro. Stem Cells. 2004;22:377–84. doi:10.1634/stemcells.22-3-377.

    Article  PubMed  Google Scholar 

  14. Chung HJ, Kim HK, Yoon JJ, Park TG. Heparin immobilized porous PLGA microspheres for angiogenic growth factor delivery. Pharm Res. 2006;23:1835–41. doi:10.1007/s11095-006-9039-9.

    Article  PubMed  CAS  Google Scholar 

  15. Lee H, Cusick RA, Browne F, Ho Kim T, Ma PX, Utsunomiya H, et al. Local delivery of basic fibroblast growth factor increases both angiogenesis and engraftment of hepatocytes in tissue-engineered polymer devices. Transplantation. 2002;73:1589–93. doi:10.1097/00007890-200205270-00011.

    Article  PubMed  CAS  Google Scholar 

  16. Perets A, Baruch Y, Weisbuch F, Shoshany G, Neufeld G, Cohen S. Enhancing the vascularization of three-dimensional porous alginate scaffolds by incorporating controlled release basic fibroblast growth factor microspheres. J Biomed Mater Res. 2003;65:489–97. doi:10.1002/jbm.a.10542.

    Article  Google Scholar 

  17. Steffens GC, Yao C, Prevel P, Markowicz M, Schenck P, Noah EM, et al. Modulation of angiogenic potential of collagen matrices by covalent incorporation of heparin and loading with vascular endothelial growth factor. Tissue Eng. 2004;10:1502–9.

    PubMed  CAS  Google Scholar 

  18. Huang YC, Kaigler D, Rice KG, Krebsbach PH, Mooney DJ. Combined angiogenic and osteogenic factor delivery enhances bone marrow stromal cell-driven bone regeneration. J Bone Miner Res. 2005;20:848–57. doi:10.1359/JBMR.041226.

    Article  PubMed  CAS  Google Scholar 

  19. Cohen H, Levy RJ, Gao J, Fishbein I, Kousaev V, Sosnowski S, et al. Sustained delivery and expression of DNA encapsulated in polymeric nanoparticles. Gene Ther. 2000;7:1896–905. doi:10.1038/sj.gt.3301318.

    Article  PubMed  CAS  Google Scholar 

  20. Cornetta K, Smith FO. Regulatory issues for clinical gene therapy trials. Hum Gene Ther. 2002;13:1143–9. doi:10.1089/104303402320138925.

    Article  PubMed  CAS  Google Scholar 

  21. Krebsbach PH, Gu K, Franceschi RT, Rutherford RB. Gene therapy-directed osteogenesis: BMP-7-transduced human fibroblasts form bone in vivo. Hum Gene Ther. 2000;11:1201–10. doi:10.1089/10430340050015248.

    Article  PubMed  CAS  Google Scholar 

  22. Peters MC, Polverini PJ, Mooney DJ. Engineering vascular networks in porous polymer matrices. J Biomed Mater Res. 2002;60:668–78. doi:10.1002/jbm.10134.

    Article  PubMed  CAS  Google Scholar 

  23. Sheridan MH, Shea LD, Peters MC, Mooney DJ. Bioabsorbable polymer scaffolds for tissue engineering capable of sustained growth factor delivery. J Control Release. 2000;64:91–102. doi:10.1016/S0168-3659(99)00138-8.

    Article  PubMed  CAS  Google Scholar 

  24. Simari RD, O’Brien T. Clinical trials in vascular gene therapy: the missing piece of the puzzle. Arch Pathol Lab Med. 2002;126:317–9.

    PubMed  CAS  Google Scholar 

  25. Bensaid M, Malecaze F, Prats H, Bayard F, Tauber JP. Autocrine regulation of bovine retinal capillary endothelial cell (BREC) proliferation by BREC-derived basic fibroblast growth factor. Exp Eye Res. 1989;48:801–13. doi:10.1016/0014-4835(89)90065-1.

    Article  PubMed  CAS  Google Scholar 

  26. Backer MV, Patel V, Jehning BT, Claffey KP, Backer JM. Surface immobilization of active vascular endothelial growth factor via a cysteine-containing tag. Biomaterials. 2006;27:5452–8. doi:10.1016/j.biomaterials.2006.06.025.

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgement

This study is funded with a grant from the Singapore A*STAR/BMRC.

Author information

Authors and Affiliations

  1. Department of Orthopaedic Surgery, National University of Singapore, Kent Ridge, Singapore, 119260, Singapore

    Tee Yong Lim, Chye Khoon Poh & W. Wang

Authors
  1. Tee Yong Lim
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Chye Khoon Poh
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. W. Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Tee Yong Lim.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lim, T.Y., Poh, C.K. & Wang, W. Poly (lactic-co-glycolic acid) as a controlled release delivery device. J Mater Sci: Mater Med 20, 1669–1675 (2009). https://doi.org/10.1007/s10856-009-3727-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10856-009-3727-z

Keywords

Search

Navigation